Mai Capital Management Portage Biotech Inc. Transaction History

Mai Capital Management

  • $10.1 Billion
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 10, 2023
BUY
$2.6 - $7.2 $55,026 - $152,380
21,164 Added 36.8%
78,676 $243,000
Q4 2022

Feb 09, 2023
BUY
$4.42 - $150.6 $254,203 - $8.66 Million
57,512 New
57,512 $304,000

Others Institutions Holding PRTG

# of Institutions
3
Shares Held
28.4K
Call Options Held
0
Put Options Held
0
View Full List

About PORTAGE BIOTECH INC.

PRTG Quotes by TradingView
  • Ticker PRTG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 16,943,700
  • Market Cap $83M
  • Description
  • Portage Biotech Inc., together with its subsidiaries, researches and develops pharmaceutical and biotechnology products. The company's product includes IMM60, an iNKT cell activator; IMM65, a PLGA-nanoparticle combined with a NY-ESO-1 peptide vaccine; INT230-6 that is in Phase I/II clinical trials for the treatment of solid tumors; STING, a smal...
More about PRTG
Track This Portfolio

Track Mai Capital Management Portfolio

Follow Mai Capital Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mai Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Mai Capital Management with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email